NC Senate Restricts Hemp THC Products in Latest State Crackdown

The North Carolina Senate approved legislation restricting hemp-derived THC and kratom products, delivering another regulatory setback for cannabis companies operating in the state's $1.2 billion hemp market. The bill passed on the final day before lawmakers entered a month-long recess, signaling growing state-level resistance to unregulated cannabis products despite federal hemp legalization.

State Regulatory Tightening Accelerates

The legislation represents part of a broader trend across conservative states moving to restrict hemp-derived products that exploit regulatory gray areas. North Carolina joins 15 other states that have enacted similar restrictions this year, creating a patchwork of regulations that complicate operations for hemp companies like Hemp Inc (HEMP), which has struggled with compliance costs and market access issues.

Senate leadership made clear the distinction between hemp restrictions and broader cannabis policy, with lawmakers stating that marijuana legalization would require separate legislative action. This approach mirrors strategies in Texas, Florida, and other states where hemp crackdowns precede broader cannabis policy debates.

Market Impact on Hemp Operators

The regulatory uncertainty continues pressuring hemp sector valuations, with the AdvisorShares Pure US Cannabis ETF down 18% year-to-date as state-level restrictions mount. Companies with significant North Carolina exposure face immediate compliance costs and potential revenue losses from product reformulations or market exits.

Hemp Inc, trading near 52-week lows, exemplifies the sector's challenges as regulatory shifts force costly operational adjustments. The company's North Carolina distribution network serves approximately 200 retail locations, representing roughly 12% of its total revenue base according to recent filings.

Compliance Costs Squeeze Margins

The bill's THC restrictions require extensive product testing and reformulation across the hemp supply chain. Industry estimates suggest compliance costs of $50,000-$100,000 per product line for testing, packaging changes, and regulatory submissions. These expenses disproportionately impact smaller operators while benefiting larger, well-capitalized companies with existing compliance infrastructure.

Kratom restrictions add another layer of complexity for retailers carrying both hemp and botanical products. The dual restrictions force inventory writedowns and supplier relationship changes that could impact Q3 earnings for affected companies.

Federal Policy Implications

North Carolina's action occurs amid ongoing federal discussions about hemp regulation and cannabis rescheduling. The DEA's proposed rule changes for hemp-derived products remain under review, while FDA enforcement of CBD health claims intensifies. State-level restrictions like North Carolina's could influence federal regulators toward stricter oversight of the hemp market.

The regulatory environment for hemp continues tightening as states move to close loopholes that allowed intoxicating products to proliferate without oversight.

The timing coincides with increased scrutiny of delta-8 THC and other hemp derivatives that produce psychoactive effects similar to traditional cannabis. Twenty-three states now restrict or ban these products, creating a fragmented market that challenges national hemp operators.

Investment Outlook Remains Challenged

The North Carolina legislation adds to headwinds facing hemp sector investments, with regulatory uncertainty deterring institutional capital. Cannabis-focused funds have reduced hemp allocations by an average of 35% this year, favoring MSOs with state-licensed operations over hemp companies navigating federal-state regulatory conflicts.

For Hemp Inc and similar operators, the path forward requires either geographic diversification away from restrictive states or pivot strategies toward compliant product formulations. The company's $2.3 million cash position provides limited runway for major strategic shifts, making near-term execution critical for maintaining market position as regulatory landscapes continue evolving.